{"id":18852,"date":"2023-01-09T15:57:52","date_gmt":"2023-01-09T07:57:52","guid":{"rendered":"https:\/\/www.shuwendx.com\/?page_id=18852"},"modified":"2024-05-13T11:09:04","modified_gmt":"2024-05-13T03:09:04","slug":"breasthealth-en","status":"publish","type":"page","link":"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/","title":{"rendered":"WOMEN'S HEALTH | BREAST HEALTH"},"content":{"rendered":"
\n \n
\n \n \n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n <\/div>\n <\/div>\n <\/div>\n
\n
\n \n \n
\n \n
\n \n
\n \n \n

WOMEN HEALTH<\/h4>\n <\/div>\n <\/div>\n
\n \n
\n \n \n

BREAST CANCER<\/h2>\n <\/div>\n <\/div>\n
\n \n \n
\n

We offer one-stop shop for proprietary diagnostic kits and testing services covering the full spectrum of breast cancer precision medicine, ranging from breast cancer risk assessment to molecular subtyping, prediction, prognosis, and\n recurrence monitoring.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
\n \n <\/path>\n <\/svg>\n <\/div>\n
\n \n <\/path>\n <\/svg>\n <\/div>\n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n
\n \n \n

Diagnostics for Full Spectrum of Breast Cancer Precision Medicine<\/h1>\n <\/div>\n <\/div>\n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n
RISK ASSESSMENT<\/span><\/a>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n \n \n
\n \n
\n \n \n <\/path>\n <\/svg><\/span><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n \n \n
\n \n
\n \n
PRECISE SCREENING<\/span><\/a>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n \n \n
\n \n
\n \n \n <\/path>\n <\/svg><\/span><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n \n \n
\n \n
\n \n
subtyping<\/span><\/a>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n \n \n
\n \n
\n \n \n <\/path>\n <\/svg><\/span><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n \n \n
\n \n
\n \n
CUSTOMIZED STRATEGY<\/span><\/a>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n \n \n
\n \n
\n \n \n <\/path>\n <\/svg><\/span><\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n \n \n
\n \n
\n \n
recurrence Monitoring<\/span><\/a>\n <\/span>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n \n
\n \n <\/path>\n <\/svg>\n <\/div>\n
\n \n <\/path>\n <\/svg>\n <\/div>\n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n
\n \n \n

1<\/h1>\n <\/div>\n <\/div>\n
\n \n
\n \n \n

risk assessment<\/h1>\n <\/div>\n <\/div>\n
\n \n
\n
\n \n \n \"\"\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n \n \n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

maxBRCA\u2122<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

Comprehensive and reliable BRCA1\/2 mutation screening detecting not only point mutations and indels, but also large rearrangements in FFPE or blood samples, enabling PARPi treatment and genetic risk determination. <\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

maxHBOC\u2122<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

Screening of 14 genes implicated in hereditary breast cancer and ovarian cancer (HBOC) detecting not only point mutations and indels, but also large rearrangements in FFPE or blood samples.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

QB56\u2122<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

Screening of mutations in 56 genes implicated in hereditary breast cancer and ovarian cancer (HBOC).<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
\n \n <\/path>\n <\/svg>\n <\/div>\n
\n \n <\/path>\n <\/svg>\n <\/div>\n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

Coming soon...<\/span><\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n
\n \n \n

2<\/h1>\n <\/div>\n <\/div>\n
\n \n
\n \n \n

Precise screening<\/h1>\n <\/div>\n <\/div>\n
\n \n
\n
\n \n \n \"\"\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n \n
\n \n <\/path>\n <\/svg>\n <\/div>\n
\n \n <\/path>\n <\/svg>\n <\/div>\n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n
\n \n \n

3<\/h1>\n <\/div>\n <\/div>\n
\n \n
\n \n \n

subtyping<\/h1>\n <\/div>\n <\/div>\n
\n \n
\n
\n \n \n \"\"\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n \n \n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

MammaTyper\u00ae<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

MammaTyper\u00ae is a standardised multiplex real-time qPCR assay co-developed by Shuwen and BioNTech (Germany). The assay kit allows pathologists to amplify, detect and quantify the mRNA expression status of 6 genes to most appropriately\n and accurately subtype breast cancer in the patients (as recommended by St Gallen, 2013 and subsequent updates).<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

FOXCARD\u2122<\/strong> Fudan Subtyping<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

An IHC kit for subtyping triple negative breast cancer (TNBC) and guiding improved TNBC therapy. It is developed based on Fudan Subtyping proposed by Professor Zhiming Shao of Fudan University Cancer Hospital. Shuwen has\n acquired patents on the technology from the hospital and collaborates with Prof. Shao for its commercialization. <\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
\n \n <\/path>\n <\/svg>\n <\/div>\n
\n \n <\/path>\n <\/svg>\n <\/div>\n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n
\n \n Luminal<\/span><\/a>\n \n Her2+<\/span><\/a>\n \n TNBC Fudan Subtyping<\/span><\/a>\n \n NGS<\/span><\/a>\n <\/div>\n
\n \n
\n \n
\n \n
\n \n \n

Prognosis and adjuvant therapy guidance<\/h4>\n <\/div>\n <\/div>\n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

MammaTyper\u00ae<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

MammaTyper\u00ae is a standardised multiplex real-time qPCR assay co-developed by Shuwen and BioNTech (Germany). The assay kit allows pathologists to amplify, detect and quantify the mRNA expression status of 6 genes to\n most appropriately and accurately subtype breast cancer in the patients (as recommended by St Gallen, 2013 and subsequent updates).<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
\n \n \n

Neoadjuvant therapy<\/h4>\n <\/div>\n <\/div>\n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

MammaTyper\u00ae<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

MammaTyper\u00ae is a standardised multiplex real-time qPCR assay co-developed by Shuwen and BioNTech (Germany). The assay kit allows pathologists to amplify, detect and quantify the mRNA expression status of 6 genes to\n most appropriately and accurately subtype breast cancer in the patients (as recommended by St Gallen, 2013 and subsequent updates).<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
\n \n \n

HER2-ADC therapy<\/h4>\n <\/div>\n <\/div>\n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

MammaTyper\u00ae<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

MammaTyper\u00ae is a standardised multiplex real-time qPCR assay co-developed by Shuwen and BioNTech (Germany). The assay kit allows pathologists to amplify, detect and quantify the mRNA expression status of 6 genes to\n most appropriately and accurately subtype breast cancer in the patients (as recommended by St Gallen, 2013 and subsequent updates).<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

CercaTest\u00ae ERBB2<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

a CE IVD proprietary kit that utilizes RT-qPCR technology to accurately and reproducibly measure the mRNA level of ERBB2 in FFPE samples of breast cancer, and may be a better selection tool for identifying patients suitable for treatment with Her2-ADC therapies.<\/span><\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
\n \n \n

CDK4\/6 Inhibitor<\/h4>\n <\/div>\n <\/div>\n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

Coming soon...<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
\n \n
\n \n
\n \n \n

HER2+ inhibitor\/antibody\/ADC<\/h4>\n <\/div>\n <\/div>\n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

MammaTyper\u00ae<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

MammaTyper\u00ae is a standardised multiplex real-time qPCR assay co-developed by Shuwen and BioNTech (Germany). The assay kit allows pathologists to amplify, detect and quantify the mRNA expression status of 6 genes to\n most appropriately and accurately subtype breast cancer in the patients (as recommended by St Gallen, 2013 and subsequent updates).<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

CercaTest\u00ae ERBB2 <\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

a CE IVD proprietary kit that utilizes RT-qPCR technology to accurately and reproducibly measure the mRNA level of ERBB2 in FFPE samples of breast cancer, and may be a better selection tool for identifying patients\n suitable for treatment with Her2-ADC therapies.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

IHC \/ FISH<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

Comprehensive evaluation of the sensitivity test of anti-HER2 targeted drugs such as trastuzumab.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
\n \n
\n \n
\n \n \n

Subtyping<\/h4>\n <\/div>\n <\/div>\n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

FOXCARD\u2122 Fudan Subtyping<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

An IHC kit for subtyping triple negative breast cancer (TNBC) and guiding improved TNBC therapy. It is developed based on Fudan Subtyping proposed by Professor Zhiming Shao of Fudan University Cancer Hospital. Shuwen\n has acquired patents on the technology from the hospital and collaborates with Prof. Shao for its commercialization.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
\n \n \n

Neoadjuvant therapy<\/h4>\n <\/div>\n <\/div>\n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

RDS\u00ae<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

The RDS\u00ae Tumor DNA Recombination Repair Defect Assessment system is the first quantitative assay to independently predict prognosis and efficacy of DNA damaged therapies for ER negative breast cancer.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
\n \n \n

HER2-ADC<\/h4>\n <\/div>\n <\/div>\n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

MammaTyper\u00ae<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

MammaTyper\u00ae is a standardised multiplex real-time qPCR assay co-developed by Shuwen and BioNTech (Germany). The assay kit allows pathologists to amplify, detect and quantify the mRNA expression status of 6 genes to\n most appropriately and accurately subtype breast cancer in the patients (as recommended by St Gallen, 2013 and subsequent updates).<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

CercaTest\u00ae ERBB2<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

a CE IVD proprietary kit that utilizes RT-qPCR technology to accurately and reproducibly measure the mRNA level of ERBB2 in FFPE samples of breast cancer, and may be a better selection tool for identifying patients suitable for treatment with Her2-ADC therapies.<\/span><\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
\n \n \n

PARP inhibitor therapy<\/h4>\n <\/div>\n <\/div>\n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

maxBRCA\u2122<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

Comprehensive and reliable BRCA1\/2 mutation screening detecting not only point mutations and indels, but also large rearrangements in FFPE or blood samples, enabling PARPi treatment and genetic risk determination. <\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
\n \n \n

Immunotherapy<\/h4>\n <\/div>\n <\/div>\n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

PD-L1\/MSI\/TMB<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

For PD-L1 staining and analysis, we offer a proprietary IHC kit we developed and registered in China. The kit has been extensively validated in various tumor types and has been used in testing tens of thousands of clinical\n trial samples for our pharmaceutical company clients.<\/p>\n

We have also developed an LDT assay for MSI that offers accurate testing of MSI status in different tumor types.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n \n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

maxBRCA\u2122<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

Comprehensive and reliable BRCA1\/2 mutation screening detecting not only point mutations and indels, but also large rearrangements in FFPE or blood samples, enabling PARPi treatment and genetic risk determination.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

maxHBOC\u2122<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

Screening of 14 genes implicated in hereditary breast cancer and ovarian cancer (HBOC) detecting not only point mutations and indels, but also large rearrangements in FFPE or blood samples.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

HRD (Homologous recombination deficiency) & DDR (DNA damage response) testing<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

Gene instability scoring (GIS) by complexing heterozygous deletion (LOH), telomere allele imbalance (TAI), and large fragment migration (LST) using the next-generation sequencing approach; Evaluating homologous recombinant\n deficient status and screening PARP inhibitor-sensitive populations based on the GIS score (HRD score) and BRCA1\/2 mutations and other 42-gene mutation(s) related to homologous recombinant repair (HRR).<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

QB42\u2122 <\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

NGS exome sequencing of 42 genes relevant to therapy selections for patients with early stage breast cancer of Luminal type.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

QB56\u2122 <\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

56-gene hereditary breast cancer testing<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

Covering 56 genes related to hereditary breast cancer with two key genes BRCA1\/2; Improving hereditary management decisions in high-risk populations, and providing clinical guidance in using PARP inhibitors.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

QB103\u2122<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

103-gene panel testing for personalized treatment of breast cancer<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

Examining relevant 103 genes in HR+ (hormone receptor positive) breast cancer using exome sequencing approach; Guiding targeted therapy, evaluating drug efficacy and toxic side effects of endocrine\/chemotherapy drugs,\n and assisting in clinical hereditary management.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

QB149\u2122<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

149-gene panel testing for personalized treatment of breast cancer<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

Examining 149 relevant genes in HR-(hormone receptor negative) breast cancer using exome sequencing approach, including genes for breast cancer targeted therapy, chemotherapy, immunotherapy, and hereditary risk.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

QB205\u2122<\/strong><\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

205-gene comprehensive breast cancer testing<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

A package designed for precision diagnosis and treatment of breast cancer by sequencing 205 genes recommended by authoritative guidelines and consensuses worldwide, meeting demands of clinical testing, medication guidance\n or genetic risk screening management requirements for different breast cancer subtypes and stages including early and advanced breast cancer patients, Luminal type or triple-negative breast cancer patients.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n \n
\n

680-gene comprehensive breast cancer testing<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

Fully meeting personalized needs of breast cancer targeted therapy, immunotherapy, endocrine therapy, and chemotherapy regimens.<\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n \n \n
\n \n
\n \n
\n \n \n

4<\/h1>\n <\/div>\n <\/div>\n
\n \n
\n \n \n

Customized strategy<\/h1>\n <\/div>\n <\/div>\n
\n \n
\n
\n \n \n \"\"\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n \n
\n \n <\/path>\n <\/svg>\n <\/div>\n
\n \n <\/path>\n <\/svg>\n <\/div>\n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n
\n \n \n

5<\/h1>\n <\/div>\n <\/div>\n
\n \n
\n \n \n

recurrence Monitoring<\/h1>\n <\/div>\n <\/div>\n
\n \n
\n
\n \n \n \"\"\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n \n \n
\n \n
\n \n
\n \n
\n
\n \n \n
\n \n
\n \n \n
\n

MRD<\/p>\n <\/div>\n <\/div>\n

\n \n \n
\n

Coming soon...<\/span><\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

WOMEN HEALTH BREAST CANCER We offer one-stop shop for p […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/full-width-page.php","meta":{"footnotes":""},"class_list":["post-18852","page","type-page","status-publish","hentry"],"yoast_head":"\nWOMEN'S HEALTH | BREAST HEALTH - SHUWEN BIOTECH<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WOMEN'S HEALTH | BREAST HEALTH - SHUWEN BIOTECH\" \/>\n<meta property=\"og:description\" content=\"WOMEN HEALTH BREAST CANCER We offer one-stop shop for p […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/\" \/>\n<meta property=\"og:site_name\" content=\"SHUWEN BIOTECH\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-13T03:09:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.shuwendx.com\/wp-content\/uploads\/2023\/10\/51miz-E1309970-21875137.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/\",\"url\":\"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/\",\"name\":\"WOMEN'S HEALTH | BREAST HEALTH - SHUWEN BIOTECH\",\"isPartOf\":{\"@id\":\"https:\/\/www.shuwendx.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.shuwendx.com\/wp-content\/uploads\/2023\/10\/51miz-E1309970-21875137.png\",\"datePublished\":\"2023-01-09T07:57:52+00:00\",\"dateModified\":\"2024-05-13T03:09:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/#primaryimage\",\"url\":\"https:\/\/www.shuwendx.com\/wp-content\/uploads\/2023\/10\/51miz-E1309970-21875137.png\",\"contentUrl\":\"https:\/\/www.shuwendx.com\/wp-content\/uploads\/2023\/10\/51miz-E1309970-21875137.png\",\"width\":9856,\"height\":7424},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"https:\/\/www.shuwendx.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WOMEN'S HEALTH | BREAST HEALTH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.shuwendx.com\/#website\",\"url\":\"https:\/\/www.shuwendx.com\/\",\"name\":\"\u6570\u95ee\u751f\u7269-SHUWEN BIOTECH\",\"description\":\"\u6570\u95ee\u751f\u7269\",\"publisher\":{\"@id\":\"https:\/\/www.shuwendx.com\/#organization\"},\"alternateName\":\"SHUWEN BIOTECH\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.shuwendx.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.shuwendx.com\/#organization\",\"name\":\"\u6d59\u6c5f\u6570\u95ee\u751f\u7269\u6280\u672f\u6709\u9650\u516c\u53f8\",\"alternateName\":\"SHUWEN BIOTECH\",\"url\":\"https:\/\/www.shuwendx.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/www.shuwendx.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.shuwendx.com\/wp-content\/uploads\/2023\/09\/112.png\",\"contentUrl\":\"https:\/\/www.shuwendx.com\/wp-content\/uploads\/2023\/09\/112.png\",\"width\":112,\"height\":112,\"caption\":\"\u6d59\u6c5f\u6570\u95ee\u751f\u7269\u6280\u672f\u6709\u9650\u516c\u53f8\"},\"image\":{\"@id\":\"https:\/\/www.shuwendx.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WOMEN'S HEALTH | BREAST HEALTH - SHUWEN BIOTECH","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/","og_locale":"zh_CN","og_type":"article","og_title":"WOMEN'S HEALTH | BREAST HEALTH - SHUWEN BIOTECH","og_description":"WOMEN HEALTH BREAST CANCER We offer one-stop shop for p […]","og_url":"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/","og_site_name":"SHUWEN BIOTECH","article_modified_time":"2024-05-13T03:09:04+00:00","og_image":[{"url":"https:\/\/www.shuwendx.com\/wp-content\/uploads\/2023\/10\/51miz-E1309970-21875137.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"6 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/","url":"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/","name":"WOMEN'S HEALTH | BREAST HEALTH - SHUWEN BIOTECH","isPartOf":{"@id":"https:\/\/www.shuwendx.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/#primaryimage"},"image":{"@id":"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/#primaryimage"},"thumbnailUrl":"https:\/\/www.shuwendx.com\/wp-content\/uploads\/2023\/10\/51miz-E1309970-21875137.png","datePublished":"2023-01-09T07:57:52+00:00","dateModified":"2024-05-13T03:09:04+00:00","breadcrumb":{"@id":"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.shuwendx.com\/en\/breasthealth-en\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/#primaryimage","url":"https:\/\/www.shuwendx.com\/wp-content\/uploads\/2023\/10\/51miz-E1309970-21875137.png","contentUrl":"https:\/\/www.shuwendx.com\/wp-content\/uploads\/2023\/10\/51miz-E1309970-21875137.png","width":9856,"height":7424},{"@type":"BreadcrumbList","@id":"https:\/\/www.shuwendx.com\/en\/breasthealth-en\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"https:\/\/www.shuwendx.com\/"},{"@type":"ListItem","position":2,"name":"WOMEN'S HEALTH | BREAST HEALTH"}]},{"@type":"WebSite","@id":"https:\/\/www.shuwendx.com\/#website","url":"https:\/\/www.shuwendx.com\/","name":"\u6570\u95ee\u751f\u7269-SHUWEN BIOTECH","description":"\u6570\u95ee\u751f\u7269","publisher":{"@id":"https:\/\/www.shuwendx.com\/#organization"},"alternateName":"SHUWEN BIOTECH","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.shuwendx.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/www.shuwendx.com\/#organization","name":"\u6d59\u6c5f\u6570\u95ee\u751f\u7269\u6280\u672f\u6709\u9650\u516c\u53f8","alternateName":"SHUWEN BIOTECH","url":"https:\/\/www.shuwendx.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/www.shuwendx.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.shuwendx.com\/wp-content\/uploads\/2023\/09\/112.png","contentUrl":"https:\/\/www.shuwendx.com\/wp-content\/uploads\/2023\/09\/112.png","width":112,"height":112,"caption":"\u6d59\u6c5f\u6570\u95ee\u751f\u7269\u6280\u672f\u6709\u9650\u516c\u53f8"},"image":{"@id":"https:\/\/www.shuwendx.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.shuwendx.com\/wp-json\/wp\/v2\/pages\/18852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.shuwendx.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.shuwendx.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.shuwendx.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.shuwendx.com\/wp-json\/wp\/v2\/comments?post=18852"}],"version-history":[{"count":0,"href":"https:\/\/www.shuwendx.com\/wp-json\/wp\/v2\/pages\/18852\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.shuwendx.com\/wp-json\/wp\/v2\/media?parent=18852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}